The FDA has decided that biosimilar medications must have unique naming features, distinguishing them from brand-name biologics in a move to improve patient safety, according to a STAT news report. 1.
Biologic medicines—drugs with complex molecules developed in living cells—have saved lives and improved the quality of life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback